Leon Kircik MD
Clinical Professor of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York; Adjunct Clinical Associate Professor of Dermatology, Indiana University School of Medicine, Indianapolis, IndianaDr. Kircik is a Board Certified Dermatologist who graduated with AOA Honors from State University of New York at the Health Sciences Center at Brooklyn after completing his undergraduate work with Phi Beta Kappa at New York University. He completed a Mohs Micrographic Surgery and Cutaneous Oncology Fellowship under the auspices of Dr. Frederick Mohs at the University of Wisconsin after completing his dermatology residency at State University of New York in Buffalo.
He currently teaches as Clinical Professor at Icahn School of Medicine at Mount Sinai Medical Center in New York City and as Adjunct Clinical Associate Professor of Dermatology at Indiana University School of Medicine. Dr. Kircik is also the Medical Director of DermResearch, PLLC, Physicians Skin Care, PLLC and Skin Sciences, PLLC in Louisville, Kentucky. He has been the principal investigator of numerous clinical trials for psoriasis, acne, rosacea, atopic dermatitis, skin cancers, and actinic keratosis, just to name a few.
Dr. Kircik is an author of many scientific articles, abstracts and posters. He has lectured extensively nationally and internationally on all aspects of dermatologic conditions. In addition, he also serves on the advisory boards of several pharmaceutical companies as a consultant. He is on the editorial board of Journal of Drugs in Dermatology, Practical Dermatology, The Journal of Clinical & Aesthetic Dermatology, and Case Report in Clinical Pathology. He volunteers for multiple local and national medical society committees.
Disclosures
Leon Kircik, MD, Financial Disclosures:
Company Name |
Type of Relationship |
Nature of Compensation |
Abbott Laboratories
|
Speaker |
H |
Abbvie |
Consultant Investigator |
H G |
Ablynx |
Investigator |
G |
Aclaris |
Advisory Board |
H |
Acambis |
Investigator |
G |
Allergan, Inc. |
Investigator Advisory Board Speaker Consultant |
H |
H |
||
H |
||
H |
||
Almirall |
Consultant Investigator Speaker Advisory Board |
H |
G H H |
||
Amgen, Inc. |
Consultant Investigator Speaker Advisory Board |
H |
G |
||
H H |
||
Anacor Pharmaceuticals |
Investigator Consultant Advisory Board |
G |
H |
||
H |
||
Anaptys |
Investigator |
G |
Arcutis |
Investigator Advisory Board Consultant |
G H H |
Arena |
Investigator Advisory Board |
G H |
Assos Pharma |
Speaker |
H |
Astellas Pharma US, Inc. |
Investigator Speaker |
G |
H |
||
Asubio |
Investigator |
G |
Bausch Health |
Investigator |
G |
Berlex Laboratories (Bayer HealthCare Pharmaceuticals) |
Investigator |
G |
Biogen-Idec |
Advisory Board |
H |
Biolife |
Investigator |
G |
Biomimterix |
Investigator |
G |
Biopelle |
Investigator |
G |
BMS |
Consultant Investigator Advisory Board |
H G H |
Boehringer-Ingleheim |
Investigator |
G |
Breckinridge Pharma |
Investigator |
G |
Cassiopea |
Consultant Advisory Board |
H |
H |
||
Centocor, Inc. |
Investigator |
G |
Cellceutix |
Investigator |
G |
Cipher |
Consultant Speaker Advisory Board |
H |
H |
||
H |
||
Coherus |
Investigator |
G |
Colbar |
Consultant Advisory Board |
H |
H |
||
Combinatrix |
Investigator |
G |
Connetics Corporation |
Advisory Board Consultant Speaker Investigator |
H |
H |
||
H |
||
G |
||
Coria |
Investigator |
G |
Dermavant |
Investigator Consultant Speaker Advisory Board |
G H H H |
Dermira |
Investigator Consultant Speaker Advisory Board |
G H H H |
Dermik Laboratories |
Speaker |
H |
Dow Pharmaceutical Sciences, Inc. |
Investigator |
G |
Dr. Reddy’s Lab |
Investigator Consultant Advisory Board |
G H H |
Dusa |
Investigator |
G |
Embil Pharmaceuticals |
Speaker |
H |
Eli Lilly |
Investigator Speaker Advisory Board Consultant |
G H H H |
EOS |
Advisory Board |
H |
Exeltis |
Advisory Board Consultant Speaker Investigator |
H |
H |
||
H |
||
G |
||
Ferndale Laboratories, Inc. |
Advisory Board Investigator |
H |
G |
||
Foamix |
Investigator Advisory Board |
G |
H |
||
Ferrer |
Consultant Speaker |
H H |
Galderma |
Consultant Speaker Advisory Board Investigator |
H |
H |
||
H |
||
G |
||
Genentech, Inc.
|
Advisory Board Speaker Investigator Consultant |
H |
H |
||
G |
||
H |
||
GlaxoSmithKline, PLC |
Investigator Speaker Consultant Advisory Board |
G H H H |
Glenmark |
Investigator Advisory Board |
G H |
Health Point, LTD |
Investigator |
G |
Idera |
Investigator |
G |
Incyte |
Investigator Advisory Board |
G H |
Intendis |
Advisory Board Consultant Investigator |
H |
H |
||
G |
||
Innocutis |
Speaker Advisory Board |
H |
H |
||
Innovail |
Speaker |
H |
Isdin |
Advisory Board |
H |
Consultant |
H |
|
Johnson & Johnson |
Consultant Investigator Advisory Board Speaker |
H |
G |
||
H |
||
H |
||
|
||
Kyowakirin |
Speaker |
H |
Laboratory Skin Care Inc. |
Consultant |
H |
Leo |
Investigator Consultant Speaker |
G |
H |
||
H |
||
L’Oreal |
Investigator Speaker |
G |
H |
||
3M |
Speaker Investigator |
H |
G |
||
Maruho |
Investigator |
G |
Medical International Technologies |
Consultant |
H |
Merck |
Consultant Investigator |
H |
G |
||
Medicis Pharmaceutical Corp. |
Investigator |
G |
Merz |
Consultant |
H |
Nano Bio |
Advisory Board Investigator |
H |
G |
||
Nektar |
Investigator |
G |
Nimbus |
Investigator |
G |
Novartis AG |
Investigator Consultant Speaker Advisory Board |
G |
H H H |
||
Noven Pharmaceuticals |
Investigator |
G |
Nucryst Pharmaceuticals Corp |
Investigator |
G |
Obagi |
Investigator |
G |
Onset |
Investigator Speaker |
G |
H |
||
OrthoNeutrogena |
Speaker Investigator Advisory Board Consultant |
H |
G |
||
H |
||
H |
||
PediaPharma |
Speaker |
H |
Pfizer |
Investigator |
G |
Promius |
Investigator Consultant Advisory Board |
G |
H |
||
H |
||
PuraCap |
Consultant |
H |
PharmaDerm |
Investigator Speaker |
G |
H |
||
QLT, Inc |
Investigator |
G |
Quinnova |
Investigator Advisory Board |
H |
H |
||
Quatrix |
Investigator |
G |
Rapt |
Investigator Consultant |
G H |
Regeneron |
Investigator Speaker |
G H |
Sanofi |
Speaker Investigator Consultant Advisory Board |
H G H H |
Serono (Merck Serono International SA) |
Speaker |
H |
SkinMedica, Inc. |
Consultant Investigator Advisory Board Speaker |
H |
G |
||
H |
||
H |
||
Stiefel Laboratories, Inc. |
Speaker Investigator Advisory Board Consultant |
H |
G |
||
H |
||
H |
||
Sun Pharma |
Consultant Advisory Board Speaker Investigator |
H H H |
G |
||
Taro |
Consultant/Speaker |
H |
TolerRx |
Investigator |
G |
Triax |
Speaker |
H |
UCB |
Investigator Consultant Speaker |
G |
H |
||
H |
||
Valeant Pharmaceuticals Intl |
Advisory Board Investigator Consultant Speaker |
H |
G |
||
H H |
||
Ventyx |
Investigator |
|
Warner-Chilcott |
Advisory Board Speaker Investigator |
H |
H |
||
G |
||
XenoPort |
Investigator |
G |
ZAGE |
Consultant |
H |
Legend: G=grant; H=honorarium
Recent Contributions to PracticeUpdate:
- Safety and Efficacy of Treatment With Deucravacitinib in Patients With Scalp Psoriasis
- Clinical Characteristics of Patients With Psoriasis With a Family History of Psoriasis
- Clinical Outcomes of COVID-19 in Patients Taking Tumor Necrosis Factor Inhibitors and/or Methotrexate
- Modifiable Risk Factors and the Development of Psoriatic Arthritis in People With Psoriasis